Evenlode Investment Management

Hugh Yarrow leads the Evenlode Income strategy as CEO and lead portfolio manager, while Ben Peters — his brother-in-law — runs Evenlode Global Income. Chris Elliott and Chris Moore serve as portfolio managers across the Global and Income strategies. All four are named operators inside the employee-owned trust, which governs the firm's capital allocation process.

Evenlode runs three long-only equity strategies: Evenlode Income, Evenlode Global Income, and Evenlode Global Opportunities. Each fund screens for cash-generative businesses with durable competitive advantages, strong balance sheets, and structural growth drivers. The firm explicitly avoids leverage, momentum strategies, and passive replication.

No. Evenlode is an independent, employee-owned firm governed through an Employee Ownership Trust. This structure was designed to align the team's incentives with long-term client outcomes rather than short-term revenue growth. The firm also holds B Corp certification, embedding social and environmental impact into its legal charter.

Evenlode's B Corp certification — with an impact score of 151.2 — reflects governance, worker, community, and environmental practices that sit inside the firm's operating model, not as a separate ESG overlay. The firm screens for strong ESG credentials within its investee universe, but the B Corp status primarily governs how Evenlode itself operates as a fiduciary, including its employee-ownership structure and stakeholder accountability mechanisms.

Yes. The Evenlode Foundation operates alongside the asset management business as a dedicated philanthropic vehicle. The firm's website and public filings reference the foundation as part of its broader commitment to social impact, though specific grant-making activity or endowment size is not publicly disclosed.

Evenlode invests in cash-generative businesses across enterprise software, consumer staples, healthcare, industrials, and media. The team seeks companies with durable moats and sustainable cash flows, and has publicly stated it avoids sectors or business models where competitive positioning cannot be assessed with high conviction over a multi-year horizon.

Idea generation is driven by bottom-up fundamental research conducted by the internal portfolio management team. The firm runs its own screening process for quality compounders and supplements this with on-the-ground due diligence — including international research trips such as the May 2026 New York visit to examine US market distortions, AI integration, and valuation dislocations.